A systematic review and meta-analysis published in Sleep Medicine Reviews found that digital cognitive behavioral therapy for insomnia (dCBT-I) had positive effects on professional activity among ...
Nxera Pharma Japan Co., Ltd. (a wholly owned subsidiary of Nxera Pharma) is the approval holder and will be responsible in part for provision of drug product. Shionogi will be solely responsible for ...
The American Academy of Sleep Medicine has issued a new position statement advocating for permanent telehealth coverage, emphasizing its essential role in providing high-quality, patient-centered care ...